drugset / Trial / NCT01967147
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry eye subjects with lipid deficiency.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propylene Glycol | Small molecule | 0.6 % | Other |